Published in Structure on April 15, 1999
Evolving strategies for the incorporation of bioinformatics within the undergraduate cell biology curriculum. Cell Biol Educ (2003) 2.54
The 193-kD vault protein, VPARP, is a novel poly(ADP-ribose) polymerase. J Cell Biol (1999) 2.14
Activation and caspase-mediated inhibition of PARP: a molecular switch between fibroblast necrosis and apoptosis in death receptor signaling. Mol Biol Cell (2002) 2.05
RNA location and modeling of a WD40 repeat domain within the vault. RNA (2000) 1.37
Engineering of vault nanocapsules with enzymatic and fluorescent properties. Proc Natl Acad Sci U S A (2005) 1.35
The vault exterior shell is a dynamic structure that allows incorporation of vault-associated proteins into its interior. Biochemistry (2006) 1.22
The Telomerase/vault-associated protein TEP1 is required for vault RNA stability and its association with the vault particle. J Cell Biol (2001) 1.15
A vault nanoparticle vaccine induces protective mucosal immunity. PLoS One (2009) 1.07
Draft crystal structure of the vault shell at 9-A resolution. PLoS Biol (2007) 1.05
Novel CCL21-vault nanocapsule intratumoral delivery inhibits lung cancer growth. PLoS One (2011) 1.01
Telomerase-associated protein TEP1 is not essential for telomerase activity or telomere length maintenance in vivo. Mol Cell Biol (2000) 1.00
Reversible pH lability of cross-linked vault nanocapsules. Nano Lett (2008) 0.97
Vault poly(ADP-ribose) polymerase is associated with mammalian telomerase and is dispensable for telomerase function and vault structure in vivo. Mol Cell Biol (2004) 0.97
Nanoscale assemblies and their biomedical applications. J R Soc Interface (2013) 0.94
The p80 homology region of TEP1 is sufficient for its association with the telomerase and vault RNAs, and the vault particle. Nucleic Acids Res (2005) 0.89
Vaults are dynamically unconstrained cytoplasmic nanoparticles capable of half vault exchange. ACS Nano (2010) 0.89
A simpler way of comparing the labelling densities of cellular compartments illustrated using data from VPARP and LAMP-1 immunogold labelling experiments. Histochem Cell Biol (2003) 0.86
Smart vaults: thermally-responsive protein nanocapsules. ACS Nano (2013) 0.84
Bioengineered vaults: self-assembling protein shell-lipophilic core nanoparticles for drug delivery. ACS Nano (2014) 0.84
The mechanism of vault opening from the high resolution structure of the N-terminal repeats of MVP. EMBO J (2009) 0.83
Unimpaired dendritic cell functions in MVP/LRP knockout mice. Immunology (2003) 0.82
Structural studies of large nucleoprotein particles, vaults. Proc Jpn Acad Ser B Phys Biol Sci (2012) 0.82
A vault ribonucleoprotein particle exhibiting 39-fold dihedral symmetry. Acta Crystallogr D Biol Crystallogr (2008) 0.79
14-3-3ε boosts bleomycin-induced DNA damage response by inhibiting the drug-resistant activity of MVP. J Proteome Res (2013) 0.78
Stem cell-based therapies for HIV/AIDS. Adv Drug Deliv Rev (2016) 0.77
Sea urchin vault structure, composition, and differential localization during development. BMC Dev Biol (2005) 0.77
Two genetic variants in telomerase-associated protein 1 are associated with stomach cancer risk. J Hum Genet (2016) 0.76
Direct visualization of vaults within intact cells by electron cryo-tomography. Cell Mol Life Sci (2015) 0.76
Dual pH- and Temperature-Responsive Protein Nanoparticles. Eur Polym J (2015) 0.75
Protein based therapeutic delivery agents: Contemporary developments and challenges. Biomaterials (2017) 0.75
Two species of lysosomal organelles in cultured human fibroblasts. Cell (1979) 3.64
Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo. Proc Natl Acad Sci U S A (2008) 3.00
Protein structure by solid-state NMR spectroscopy. Q Rev Biophys (1987) 2.27
The transport of lysosomal enzymes. J Supramol Struct (1977) 2.22
Mutation R120G in alphaB-crystallin, which is linked to a desmin-related myopathy, results in an irregular structure and defective chaperone-like function. Proc Natl Acad Sci U S A (1999) 2.18
The 193-kD vault protein, VPARP, is a novel poly(ADP-ribose) polymerase. J Cell Biol (1999) 2.14
mu-Opioid receptor internalization: opiate drugs have differential effects on a conserved endocytic mechanism in vitro and in the mammalian brain. Mol Pharmacol (1998) 2.14
The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules. Immunity (1997) 2.07
The small heat-shock protein, alphaB-crystallin, has a variable quaternary structure. J Mol Biol (1998) 1.98
Isolation and characterization of a novel ribonucleoprotein particle: large structures contain a single species of small RNA. J Cell Biol (1986) 1.98
Direct demonstration of binding of a lysosomal enzyme, alpha-L-iduronidase, to receptors on cultured fibroblasts. Proc Natl Acad Sci U S A (1979) 1.97
Role of alpha(v) integrins in adenovirus cell entry and gene delivery. Microbiol Mol Biol Rev (1999) 1.90
Structural requirements for time-dependent inhibition of prostaglandin biosynthesis by anti-inflammatory drugs. Proc Natl Acad Sci U S A (1975) 1.86
Vaults are up-regulated in multidrug-resistant cancer cell lines. J Biol Chem (1998) 1.74
Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1. J Immunol (1999) 1.69
Structure of adenovirus complexed with its internalization receptor, alphavbeta5 integrin. J Virol (1999) 1.57
Vaults. III. Vault ribonucleoprotein particles open into flower-like structures with octagonal symmetry. J Cell Biol (1991) 1.57
Small heat-shock protein structures reveal a continuum from symmetric to variable assemblies. J Mol Biol (2000) 1.55
Coated vesicles from rat liver and calf brain contain lysosomal enzymes bound to mannose 6-phosphate receptors. J Biol Chem (1983) 1.54
Assembly of vault-like particles in insect cells expressing only the major vault protein. J Biol Chem (2001) 1.54
Vaults and telomerase share a common subunit, TEP1. J Biol Chem (1999) 1.50
Evidence that vault ribonucleoprotein particles localize to the nuclear pore complex. J Cell Sci (1993) 1.49
Assay and purification of a solubilized membrane receptor that binds the lysosomal enzyme alpha-L-iduronidase. Arch Biochem Biophys (1982) 1.46
Vaults. II. Ribonucleoprotein structures are highly conserved among higher and lower eukaryotes. J Cell Biol (1990) 1.42
A helper-independent adenovirus vector with E1, E3, and fiber deleted: structure and infectivity of fiberless particles. J Virol (1999) 1.39
Human kidney alpha-L-iduronidase: purification and characterization. Arch Biochem Biophys (1978) 1.39
RNA location and modeling of a WD40 repeat domain within the vault. RNA (2000) 1.37
Solid-state nuclear magnetic resonance structural studies of proteins. Methods Enzymol (1989) 1.29
Vault ribonucleoprotein particles from rat and bullfrog contain a related small RNA that is transcribed by RNA polymerase III. J Biol Chem (1993) 1.28
Coated vesicles from rat liver and calf brain contain cryptic mannose 6-phosphate receptors. J Biol Chem (1983) 1.26
Insights into adenovirus host cell interactions from structural studies. Virology (2008) 1.25
Method development and subsequent survey analysis of biological tissues for platinum, lead, and manganese content. Environ Health Perspect (1975) 1.24
Cryo-EM imaging of the catalytic subunit of the DNA-dependent protein kinase. J Mol Biol (1998) 1.21
The Telomerase/vault-associated protein TEP1 is required for vault RNA stability and its association with the vault particle. J Cell Biol (2001) 1.15
Up-regulation of vaults may be necessary but not sufficient for multidrug resistance. Int J Cancer (2001) 1.10
Lens alpha-crystallin: function and structure. Eye (Lond) (1999) 1.10
Preparative agarose gel electrophoresis for the purification of small organelles and particles. Anal Biochem (1986) 1.07
Acetyl coenzyme A: alpha-glucosaminide N-acetyltransferase. Evidence for a transmembrane acetylation mechanism. J Biol Chem (1985) 1.07
PCR-based cystic fibrosis (CF) carrier screening in a first-year medical student biochemistry laboratory. Am J Hum Genet (1993) 1.06
Structural analysis of a fiber-pseudotyped adenovirus with ocular tropism suggests differential modes of cell receptor interactions. J Virol (2001) 1.04
Myelination in cerebellar slice cultures: development of a system amenable to biochemical analysis. J Neurosci Res (1993) 1.03
Vaults are the answer, what is the question? Trends Cell Biol (1996) 1.00
Analysis of sulfatide from rat cerebellum and multiple sclerosis white matter by negative ion electrospray mass spectrometry. Biochim Biophys Acta (2000) 0.99
QVIEW: software for rapid selection of particles from digital electron micrographs. J Struct Biol (1998) 0.99
Vault immunofluorescence in the brain: new insights regarding the origin of microglia. J Neurosci (1991) 0.99
Lysosomal enzyme precursors in coated vesicles derived from the exocytic and endocytic pathways. J Cell Biol (1987) 0.98
Butanedione treatment reduces receptor binding of a lysosomal enzyme to cells and membranes. Biochem Biophys Res Commun (1980) 0.97
Genetic evidence for transmembrane acetylation by lysosomes. Science (1986) 0.96
Degradation of mucopolysaccharide in intact isolated lysosomes. J Biol Chem (1981) 0.95
Crystallization and preliminary X-ray diffraction analysis of human adenovirus. Virology (2010) 0.94
Subpopulations of liver coated vesicles resolved by preparative agarose gel electrophoresis. J Cell Biol (1986) 0.94
Lysosomal degradation of glycoproteins and glycosaminoglycans. Efflux and recycling of sulphate and N-acetylhexosamines. Biochem J (1986) 0.94
Cryo-electron microscopic localization of protein L7/L12 within the Escherichia coli 70 S ribosome by difference mapping and Nanogold labeling. J Biol Chem (2001) 0.93
Interaction of rat liver lysosomal membranes with actin. J Cell Biol (1984) 0.92
The sequence of a cDNA encoding the major vault protein from Rattus norvegicus. Gene (1994) 0.92
Glass micro-fibers: a model system for study of early events in myelination. J Neurosci Res (1990) 0.91
Dictyostelium vaults: disruption of the major proteins reveals growth and morphological defects and uncovers a new associated protein. J Biol Chem (1995) 0.91
Utilization of exogenously added acetyl coenzyme A by intact isolated lysosomes. J Biol Chem (1983) 0.90
Designing a clinician-user interface for a health care information system. Healthc Inf Manage (1996) 0.90
RGD-containing peptides inhibit the synthesis of myelin-like membrane by cultured oligodendrocytes. J Cell Biol (1988) 0.90
Synthesis of a myelin-like membrane by oligodendrocytes in culture. J Neurosci Res (1986) 0.90
Cryoelectron microscopic examination of human immunodeficiency virus type 1 virions with mutations in the cyclophilin A binding loop. J Virol (1998) 0.90
Aspirin as a quantitative acetylating reagent for the fatty acid oxygenase that forms prostaglandins. Prostaglandins (1976) 0.89
cDNA cloning and disruption of the major vault protein alpha gene (mvpA) in Dictyostelium discoideum. J Biol Chem (1993) 0.89
A survey of obstetrician-gynecologists' abortion attitudes and performances. Med Care (1978) 0.88
The rat vault RNA gene contains a unique RNA polymerase III promoter composed of both external and internal elements that function synergistically. J Biol Chem (1994) 0.88
Stimulation of in vitro myelin synthesis by microglia. Glia (1994) 0.87
Patterns of elemental excretion in long term balance studies. Health Phys (1969) 0.86
Functional evidence for the role of axolemma in CNS myelination. Neuron (1994) 0.86
Vaults: large cytoplasmic RNP's that associate with cytoskeletal elements. Mol Biol Rep (1990) 0.85
Image restrained modeling of alphaB-crystallin. Exp Eye Res (1999) 0.84
The Mr 193,000 vault protein is up-regulated in multidrug-resistant cancer cell lines. Cancer Res (2000) 0.84
Impaired clearance of free cystine from lysosome-enriched granular fractions of I-cell-disease fibroblasts. Biochem J (1986) 0.84
Relationship of LRP-human major vault protein to in vitro and clinical resistance to anticancer drugs. Cytotechnology (1996) 0.84
Role of axonal components during myelination. Microsc Res Tech (1998) 0.84
The toxicity of phomopsin for sheep. Aust Vet J (1987) 0.84
Aberrant expression and localization of the cytoskeleton-binding pp52 (LSP1) protein in hairy cell leukemia. Leuk Res (2001) 0.83
Prostaglandin biosynthesis: consequences of oxygenase mechanism upon in vitro assays of drug effectiveness. Adv Prostaglandin Thromboxane Res (1976) 0.82
Acetyl-coenzyme A:alpha-glucosaminide N-acetyltransferase. Evidence for an active site histidine residue. J Biol Chem (1986) 0.82
Development of a toxin-binding agent as a treatment for tunicaminyluracil toxicity: protection against tunicamycin poisoning of sheep. Aust Vet J (1998) 0.81
Expression of a beta 1-related integrin by oligodendroglia in primary culture: evidence for a functional role in myelination. J Cell Biol (1994) 0.81
Expression of multiple integrins and extracellular matrix components by C6 glioma cells. J Neurosci Res (1992) 0.80
Lysosomal function in the degradation of defective collagen in cultured lung fibroblasts. Biochemistry (1984) 0.79
Evidence for ligand- and pH-dependent conformational changes in liposome-associated mannose 6-phosphate receptor. J Biol Chem (1987) 0.79
Properties of a partially-purified preparation of the prostaglandin-forming oxygenase from sheep vesicular gland. Prostaglandins (1975) 0.79
Evidence that an RGD-dependent receptor mediates the binding of oligodendrocytes to a novel ligand in a glial-derived matrix. J Cell Biol (1988) 0.79
Antibody neutralization epitopes and integrin binding sites on nonenveloped viruses. Virology (2001) 0.78
Cation-independent mannose 6-phosphate receptor contains covalently bound fatty acid. J Cell Biochem (1988) 0.78
Cloning of a cDNA encoding a sequence-specific single-stranded-DNA-binding protein from Rattus norvegicus. Gene (1999) 0.78
Permanent testicular damage induced in rats by a single dose of tunicamycin. Reprod Toxicol (1997) 0.77
Axonal proteins involved in myelination: characterization of a collagen-like protein. Dev Neurosci (1997) 0.76
A protein involved in central nervous system myelination: localization in the extracellular matrix and induction in neuroblastoma cells. Dev Neurosci (1994) 0.76
Incorporation of mannose 6-phosphate receptors into liposomes. Receptor topography and binding of alpha-mannosidase. Biochem J (1983) 0.75
Cloning and sequence of the cDNA encoding the rat oligodendrocyte integrin beta 1 subunit. Gene (1995) 0.75
Uptake and binding of alpha-L-iduronidase. Methods Enzymol (1982) 0.75